The UKRI-AIDD Doctoral Training Programme builds capacity and capability through interdisciplinary research. Our programme will ensure sustainability of the pipeline of scientific skills in a next generation cohort of drug discovery scientists.— Dr Mani Mudaliar, Director, Quantitative Biomarkers at Recursion. AIDD Industry Lead
Recursion is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distil from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
For more information please click to access Twitter, Linkedin, or visit our website.
Further information on our selection criteria, who we are looking for, how to apply, and frequently asked questions.
Each project will be led by one student, with academic and industry supervision. Click through to see each project title and their summary.
There is plenty of guidance and tips online for PhD candidates, for example in the FindaPhD website where our programme will be advertised.